Aptose Biosciences Inc. - Common Shares (APTO)
CUSIP: 03835T309
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Shares
- Shares outstanding
- 2,587,950
- Total 13F shares
- 1,075,178
- Share change
- +123,529
- Total reported value
- $3,010,563
- Price per share
- $2.80
- Number of holders
- 24
- Value change
- +$253,698
- Number of buys
- 6
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 03835T309?
CUSIP 03835T309 identifies APTO - Aptose Biosciences Inc. - Common Shares in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03835T309:
Top shareholders of APTO - Aptose Biosciences Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Donald R. Wilson Jr. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,892,437
|
$12,885,141 | — | 03 Aug 2021 | |
| DRW Securities, LLC |
13F
|
Company |
23%
|
592,829
|
$2,751,000 | — | 30 Jun 2023 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
5.7%
|
146,232
|
$678,516 | — | 30 Jun 2023 | |
| Carlson Capital, L.P. |
13F
|
Company |
4.1%
|
106,666
|
$494,930 | — | 30 Jun 2023 | |
| Annandale Capital, LLC |
13F
|
Company |
2.1%
|
53,332
|
$247,000 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
47,082
|
$218,461 | — | 30 Jun 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
35,472
|
$164,590 | — | 30 Jun 2023 | |
| Voss Capital, LP |
13F
|
Company |
0.57%
|
14,634
|
$67,902 | — | 30 Jun 2023 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.28%
|
7,345
|
$44,364 | — | 30 Jun 2023 | |
| US BANCORP \DE\ |
13F
|
Company |
0.08%
|
2,020
|
$9,373 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
1,526
|
$8,000 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.07%
|
1,712
|
$7,943 | — | 30 Jun 2023 | |
| Gleason Group, Inc. |
13F
|
Company |
0.05%
|
1,216
|
$5,642 | — | 30 Jun 2023 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.04%
|
965
|
$4,478 | — | 30 Jun 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.02%
|
420
|
$1,949 | — | 30 Jun 2023 | |
| HighMark Wealth Management LLC |
13F
|
Company |
0.01%
|
300
|
$1,392 | — | 30 Jun 2023 | |
| Beaird Harris Wealth Management, LLC |
13F
|
Company |
0.01%
|
250
|
$1,160 | — | 30 Jun 2023 | |
| Johnson Midwest Financial, LLC |
13F
|
Company |
0.01%
|
151
|
$701 | — | 30 Jun 2023 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.01%
|
133
|
$617 | — | 30 Jun 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
115
|
$534 | — | 30 Jun 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
102
|
$465 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
100
|
$464 | — | 30 Jun 2023 | |
| CALDWELL SUTTER CAPITAL, INC. |
13F
|
Company |
0%
|
92
|
$427 | — | 30 Jun 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
29
|
$135 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
27
|
$125 | — | 30 Jun 2023 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
1
|
$5 | — | 30 Jun 2023 | |
| Jotin Marango |
3/4/5
|
Senior VP, CFO, and CBO |
—
class O/S missing
|
600,000
|
— | — | 18 Jan 2022 | |
| Caroline M. Loewy |
3/4/5
|
Former Director |
—
class O/S missing
|
50,000
|
— | — | 31 May 2022 |
Institutional Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q3 2023
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.